Impact of translation availability on the patient voice in clinical trials: commentary.

Kuliś D, Eremenco S, Hedderly L, Leek DE, Popielnicki AA, Potz E

Open source

DOI
10.1186/s41687-026-01156-4
Published
2026 Jul 21
Container
Journal of patient-reported outcomes
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s41687-026-01156-4,
  title = {Impact of translation availability on the patient voice in clinical trials: commentary.},
  author = {Kuliś D and Eremenco S and Hedderly L and Leek DE and Popielnicki AA and Potz E},
  year = {2026},
  journal = {Journal of patient-reported outcomes},
  doi = {10.1186/s41687-026-01156-4},
  url = {https://doi.org/10.1186/s41687-026-01156-4}
}

RIS

TY  - JOUR
TI  - Impact of translation availability on the patient voice in clinical trials: commentary.
AU  - Kuliś D
AU  - Eremenco S
AU  - Hedderly L
AU  - Leek DE
AU  - Popielnicki AA
AU  - Potz E
PY  - 2026
JO  - Journal of patient-reported outcomes
DO  - 10.1186/s41687-026-01156-4
UR  - https://doi.org/10.1186/s41687-026-01156-4
ER  - 

APA

D, K., S, E., L, H., DE, L., AA, P., & E, P. (2026). Impact of translation availability on the patient voice in clinical trials: commentary.. Journal of patient-reported outcomes. https://doi.org/10.1186/s41687-026-01156-4

Source records